IRCCS Istituto Giannina Gaslini, Genoa, Italy
Genoa, Genoa, Italy
Prof Angelo Ravelli, MD, is Scientific Director of the Giannina Gaslini Institute in Genoa, Italy. He is also Professor of Pediatrics at the University of Genoa. His field of clinical and research activity focuses on pediatric rheumatology.
He has received numerous grants and awards, including a grant from the American College of Rheumatology (ACR) and European League Against Rheumatism (EULAR) to conduct the project aimed to develop the new classification criteria for macrophage activation syndrome in systemic juvenile idiopathic arthritis. Dr. Ravelli was the chairman of the International Consensus Conference which led to the development of the 2016 classification criteria for macrophage activation syndrome in systemic juvenile idiopathic arthritis and of the International Task Force that developed the recommendations for the treat-to-target Strategy in juvenile idiopathic arthritis.
He is currently President of the Pediatric Rheumatology European Society (PReS) and past-President of the Italian Society of Pediatric Rheumatology (ReumaPed).
12S126: Long COVID Mechanisms and Approach to Pediatric Care
Sunday, November 12, 2023
12:00 PM – 1:00 PM PT
Disclosure(s): AbbVie/Abbott: honoraria for consultancies or speaker bureaus from (Ongoing); Novartis: honoraria for consultancies or speaker bureaus from (Ongoing); Pfizer: honoraria for consultancies or speaker bureaus from (Ongoing)
Tuesday, November 14, 2023
2:45 PM – 2:55 PM PT
Disclosure(s): AbbVie/Abbott: honoraria for consultancies or speaker bureaus from (Ongoing); Novartis: honoraria for consultancies or speaker bureaus from (Ongoing); Pfizer: honoraria for consultancies or speaker bureaus from (Ongoing)